Correction to: Higher angiotensin‑converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease

Acta Neuropathol Commun. 2023 Nov 1;11(1):173. doi: 10.1186/s40478-023-01678-8.

Louise Reveret^{1

2}, Manon Leclerc^{1

2}, Vincent Emond², Cyntia Tremblay², Andréanne Loiselle², Philippe Bourassa^{1

2}, David A Bennett³, Sébastien S Hébert^{2

4}, Frédéric Calon^{5

6}

¹ Faculty of Pharmacy, Laval University, Quebec, QC, Canada.
² CHU de Quebec Research Center, 2705, Boulevard Laurier, Room T2?05, Quebec, QC G1V 4G2, Canada.
³ Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
⁴ Faculty of Medicine, Laval University, Quebec, QC, Canada.
⁵ Faculty of Pharmacy, Laval University, Quebec, QC, Canada. Frederic.calon@pha.ulaval.ca.
⁶ CHU de Quebec Research Center, 2705, Boulevard Laurier, Room T2?05, Quebec, QC G1V 4G2, Canada. Frederic.calon@pha.ulaval.ca.

No abstract available

Publication types